Abstract
Behavioral side effects associated with clonazepam may include agitation, aggression, hyperactivity, irritability, property destruction, and temper tantrums. These side effects may be inadvertently confused with other behavioral or psychiatric conditions, especially if exacerbation of existing challenging behavior occurs. This report describes an individual with mental retardation who experienced behavioral exacerbation associated with clonazepam prescribed at 2 mg/day (0.02 mg/kg/day) to treat aggression, self-injurious behavior, property destruction, and screaming, which was measured with a 15-minute partial interval recording measurement method. When clonazepam was reduced and discontinued, these behaviors significantly decreased from 3.1% of intervals (95% confidence band = 1.6% to 4.6%) to 0.1% of intervals (95% confidence band = 0% to 0.1%). Indicators suggesting review by appropriate medical personnel for possible clonazepam behavioral side effects are provided.
This is a preview of subscription content, log in via an institution to check access.
References
Alvarez, N., Besag, F., & Iivanainen, M. (1998). Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability, Journal of Intellectual Disability Research, 42, (Suppl. 1), 1-15.
Aman, M. G., Sarphare, G., & Burrow, W. H. (1995). Psychotropic drugs in group homes: Prevalence and relation to demographic/ psychiatric variables. American Journal on Mental Retardation. 99, 500-509.
Ashton, H. (1994). Guidelines for the rational use of benzodiazepines. Drugs, 48, 25-40.
Awaad, Y., Munoz, S., & Nigro, M. (1999). Progressive dystonia in a child with chromosome 18p deletion, treated with intrathecal baclofen. Journal of Child Neurology, 14, 75-77.
Blair, R. J. R., & Curran, H. V. (1999). Selective impairment in the recognition of anger induced by diazepam. Psychopharmacology, 147, 335-338.
Bond, A. J. (1998). Drug-induced behavioural disinhibition. Incidence, mechanisms, and therapeutic implications. CNS Drugs, 9, 41-57.
Bond, A. J., Curran, H. V., Bruce, M. S., O'Sullivan, G., & Shine, P. (1995). Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam. Journal of Affective Disorders, 35, 117-123.
Browne, T. R. (1978). Clonazepam. New England Journal of Medicine, 299, 812-816.
Commander, M., Green, S. H., & Pendergast, M. (1991). Behavioral disturbances in children treated with clonazepam. Developmental Medicine and Child Neurology, 33, 362-363.
Dreifuss, F. E., Penry, J. K., Rose, S. W., Kupferberg, H. J., Dyken, P., & Sato, S. (1975). Serum clonazepam concentrations in children with absence seizures. Neurology, 25, 255-258.
Edwards, R. A., & Medlicott, R. W. (1980). Advantages and disadvantages of benzodiazepines. New Zealand Medical Journal, 92, 357-379.
Eeg-Olofsson, O. (1973). Experiences with Rivotril® in treatment of epilepsy particularly minor motor epilepsy in mentally retarded children. Acta Neurologia Scandinavica, 49 (Suppl. 53), 29-31.
Freinhar, J. P. (1985). Clonazepam treatment of a mentally retarded woman. American Journal of Psychiatry 142, 1513.
Gillberg, C. (1991). The treatment of epilepsy in autism. Journal of Autism and Developmental Disorders, 21, 61-77.
Golden, A. G., Preston, R. A., Barnett, S. D., Llorente, M., Hamdan, K., & Silverman, M. A. (1999). Inappropriate medication prescribing in homebound older adults. Journal of the American Geriatrics Society, 47, 948-953.
Good, D. C., & Howard, H. D. (1982). Myoclonus in Down's Syndrome: Treatment with clonazepam. Archives of Neurology, 39, 195.
Graae, F., Milner, J., Rizzotto, L., & Klein, R. G. (1994). Clonazepam in childhood anxiety disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 33, 372-376.
Hirvasniemi, A., Herrala, P., & Leisti, J. (1995). Northern epilepsy syndrome: Clinical course and the effect of medication on seizures. Epilepsia, 36, 792-797.
Kalachnik, J. E., Hanzel, T. E., Harder, S. R., Bauernfeind, J. D., & Engstrom, E. A. (1995). Antiepileptic drug behavioral side effects in individuals with mental retardation and the use of behavioral measurement techniques. Mental Retardation, 33, 374-382.
Khreim, I., & Mikkelsen, E. (1997). Anxiety disorders in adults with mental retardation. Psychiatric Annals, 27, 175-181.
Luiselli, J. K., Blew, P., Keane, J., Thibadeau, S., & Holzman, T. (2000). Pharmacotherapy for severe aggression in a child with autism: “Open label” evaluation of multiple medications on response frequency and intensity of behavioral intervention. Journal of Behavior Therapy, 31, 219-230.
Nakamura, M., Yamagata, T., Momoi, M. Y., & Yamazaki, T. (1998). Drop episodes in Coffin-Lowry syndrome: Exaggerated startle responses treated with clonazepam. Pediatric Neurology, 19, 148-150.
Pary, R. (1993). Psychotropic drugs used with adults and elderly adults who have mental retardation. American Journal on Mental Retardation, 98, 121-127.
Physicians' desk reference (54th ed.) (2000). Montvale, NJ: Medical Economics.
Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., & Zito, J. M. (1998). Prescribing trends in psychotropic medications. Primary care, psychiatry, and other medical specialties. Journal of the American Medical Association, 279, 526-531.
Rosenbaum, J. F., Moroz, G., & Bowden, C. L. (1997). Clonazepam in the treatment of panic disorder with or without agoraphobia: A dose-response study of efficacy, safety, and discontinuance. Journal of Clinical Psychopharmacology, 17, 390-400.
Rosenfeld, W. E., Beniak, T. E., Lippmann, S. M., & Loewenson, R. B. (1987). Adverse behavioral response to clonazepam as a function of verbal IQ-performance IQ discrepency. Epilepsy Research, 1, 347-356.
Salzman, C., Kochansky, G. E., Shader, R. I., Porrino, L. J., Harmatz, J. S., & Swett, C. P. (1974). Chlordiazepoxide-induced hostility in a small group setting. Archives of General Psychiatry, 31, 401-405.
Schenck, C. H., & Mahowald, M. W. (1995). Two cases of premenstrual sleep terrors and injurious sleep-walking. Journal of Psychosomatic Obstetrics and Gynecology, 16, 79-84.
Scher, C. S., & Anwar, M. (1999). The self-reporting of psychiatric medications in patients scheduled for elective surgery. Journal of Clinical Anesthesiology, 11, 619-621.
Schmidt, E. V., Byars, J. R., & Gruber, J. (2001). Overview of psychotropic and nontraditional medication therapy in a mentally retarded/developmentally disabled population. Consultant Pharmacist, 16, 365-370.
Singh, B. K., & Towle, P. O. (1993). Antiepiletic drug status in adult outpatients with mental retardation. American Journal on Mental Retardation, 98 (Suppl.), 41-46.
Spreat, S., Conroy, J. W., & Jones, J. C. (1997). Use of psychotropic medication in Oklahoma: A statewide survey. American Journal on Mental Retardation, 102, 80-85.
Thompson, T., & Symons, F. J. (1999). Psychotropic medication treatment for destructive behavior based on neurobehavioral mechanisms of drug action. In N. A. Wieseler & R. H. Hanson (Eds.), Challenging behavior of persons with mental health disorders and severe developmental disabilities (pp. 125-150). Washington, DC: American Association on Mental Retardation.
Werry, J. S. (1998). Anxiolytics and sedatives. In S. Reiss & M. G. Aman (Eds.), Psychotropic medication and developmental disabilities. The international consensus handbook (pp. 201-214). Columbus: Ohio State University Nisonger Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalachnik, J.E., Hanzel, T.E., Sevenich, R. et al. Brief Report: Clonazepam Behavioral Side Effects with an Individual with Mental Retardation. J Autism Dev Disord 33, 349–354 (2003). https://doi.org/10.1023/A:1024466819989
Issue Date:
DOI: https://doi.org/10.1023/A:1024466819989